Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: A meta-analysis
CZ Li, P Zhang, RW Li, CT Wu, XP Zhang… - European Journal of …, 2015 - Elsevier
Background In early breast cancer patients with sentinel node metastasis, the effect of
axillary lymph node dissection (ALND) is controversial. The purpose of this study is to …
axillary lymph node dissection (ALND) is controversial. The purpose of this study is to …
Sentinel node biopsy for breast cancer: past, present, and future
K Motomura - Breast Cancer, 2015 - Springer
Sentinel node biopsy has replaced axillary lymph node dissection as the standard of care in
early breast cancers. Sentinel node biopsy represents a highly accurate and less-morbid …
early breast cancers. Sentinel node biopsy represents a highly accurate and less-morbid …
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and 18F-FDG …
S You, DK Kang, YS Jung, YS An… - The British journal of …, 2015 - academic.oup.com
Objective: To evaluate the diagnostic performance of ultrasound, MRI and fluorine-18
fludeoxyglucose positron emission tomography (18F-FDG PET)/CT for the diagnosis of …
fludeoxyglucose positron emission tomography (18F-FDG PET)/CT for the diagnosis of …
Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast …
K Yao, E Liederbach, C Pesce, CH Wang… - Journal of the American …, 2015 - Elsevier
Background The Z0011 trial showed similar outcomes between sentinel node biopsy (SNB)
alone and axillary node dissection (ALND) for early-stage breast cancer, but few studies …
alone and axillary node dissection (ALND) for early-stage breast cancer, but few studies …
Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes
C Bonneau, D Hequet, JP Estevez, N Pouget… - European Journal of …, 2015 - Elsevier
Aim The objective of this study was to determine the effects of axillary lymph node dissection
(ALND) versus sentinel lymph node biopsy alone (SLNB) on the survival of patients with 3 or …
(ALND) versus sentinel lymph node biopsy alone (SLNB) on the survival of patients with 3 or …
Axillary lymph node burden in invasive breast cancer: a comparison of the predictive value of ultrasound-guided needle biopsy and sentinel lymph node biopsy
BA Boone, C Huynh, ML Spangler, J Sumkin… - Clinical breast …, 2015 - Elsevier
Background Recent studies suggest that axillary lymph node dissection (ALND) may be
omitted in select breast cancer patients with a positive sentinel lymph node biopsy (SLNB) …
omitted in select breast cancer patients with a positive sentinel lymph node biopsy (SLNB) …
[HTML][HTML] Sentinel lymph node biopsy alone after neoadjuvant chemotherapy in patients with initial cytology-proven axillary node metastasis
JY Kim, MK Kim, JE Lee, Y Jung, SY Bae… - Journal of breast …, 2015 - ncbi.nlm.nih.gov
Purpose Neoadjuvant chemotherapy (NAC) has been recently used to downstage breast
cancer. However, in patients with initial axillary lymph node (ALN) metastasis, ALN …
cancer. However, in patients with initial axillary lymph node (ALN) metastasis, ALN …
Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion
HH Milioli, KS Sousa, R Kaviski… - Cancer Genomics & …, 2015 - cgp.iiarjournals.org
Background: Lymph node metastasis is an important clinicopathological parameter for
breast cancer prognostication and treatment. Although the development of metastasis is …
breast cancer prognostication and treatment. Although the development of metastasis is …
Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study
We estimated the impact of axillary lymph node dissection (ALND) on the risk of axillary
recurrence (AR) and overall survival (OS) in breast cancer patients with micrometastases or …
recurrence (AR) and overall survival (OS) in breast cancer patients with micrometastases or …